XML 25 R17.htm IDEA: XBRL DOCUMENT v3.23.1
CB Oncology Partners (Tables)
3 Months Ended
Mar. 31, 2023
CB Oncology Partners LLC [Member]  
Schedule of Equity Method Investments [Line Items]  
Equity Method Investment Summarized Financial Information

The following table presents the summarized financial information of CBOP:


CBOP Condensed Income Statement Information

   
Three Months Ended
 
    March 31,  
   
2023
   
2022
 
             
Patient revenue
  $ 318,000     $
582,000  
                 
Net (loss) income
  $ (287,000 )   $
(46,000 )
                 
USNC’s equity in (loss) income of CBOP
  $ (82,000 )   $
(13,000 )


CBOP Condensed Balance Sheet Information

   
March 31,
   
December 31,
 
   
2023
   
2022
 
             
Current assets
 
$
364,000
   
$
405,000
 
                 
Noncurrent assets
   
2,910,000
     
3,056,000
 
                 
Total assets
 
$
3,274,000
   
$
3,461,000
 
                 
Current liabilities
 
$
3,770,000
   
$
975,000
 
                 
Noncurrent liabilities
   
2,985,000
     
5,680,000
 
                 
Deficit
   
(3,481,000
)
   
(3,194,000
)
                 
Total liabilities and deficit
 
$
3,274,000
   
$
3,461,000